TRIM21 and COVID-19: Cremonesi et al. [46] reported B-cell activation and production of antibodies against two cardiac antigens (TRIM21 and SNRNP70) in a small group of patients with delayed enhancement on 6-month follow-up MRI examination who had had high-sensitivity troponin elevation during hospitalization for COVID-19.